Use of Proprietary Names by Prescribers for Discontinued Brand Drug Products With Existing Generic Equivalents

被引：0
|
作者：
Chi-Ming Tu
Kellie Taylor
Grace Chai
机构：
[1] Food and Drug Administration,Center for Drug Evaluation and Research/Office of Surveillance and Epidemiology/Office of Medication Error Prevention and Risk Management/Division of Medication Error Prevention and Analysis
[2] Food and Drug Administration,Center for Drug Evaluation and Research/Office of Surveillance and Epidemiology/Office of Pharmacovigilance and Epidemiology/Division of Epidemiology II
来源：
Drug information journal : DIJ / Drug Information Association | 2012年 / 46卷
关键词：
prescribing practice; proprietary name; discontinued drug; drug name confusion; medication error;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：677 / 682
页数：5
相关论文
共 5 条
  • [1] Use of Proprietary Names by Prescribers for Discontinued Brand Drug Products With Existing Generic Equivalents
    Tu, Chi-Ming
    Taylor, Kellie
    Chai, Grace
    DRUG INFORMATION JOURNAL, 2012, 46 (06): : 677 - 682
  • [2] Use of Proprietary Names by Prescribers for Generic Products
    Vicky Borders-Hemphill
    Irene Z. Chan
    Katelyn Brown
    Briana Rider
    Kellie Taylor
    Grace Chai
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 256 - 260
  • [3] Use of Proprietary Names by Prescribers for Generic Products
    Borders-Hemphill, Vicky
    Chan, Irene Z.
    Brown, Katelyn
    Rider, Briana
    Taylor, Kellie
    Chai, Grace
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (02) : 256 - 260
  • [4] Use of Proprietary Names by Prescribers When Prescribing Over-the-Counter (OTC) Drug Products
    Tu, Chi-Ming
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2019, 53 (01) : 132 - 137
  • [5] Use of Proprietary Names by Prescribers When Prescribing Over-the-Counter (OTC) Drug Products
    Chi-Ming Tu
    Therapeutic Innovation & Regulatory Science, 2019, 53 : 132 - 137
1